These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2347953)
21. [European drug policy]. Sauer F Bull Mem Acad R Med Belg; 1993; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930 [TBL] [Abstract][Full Text] [Related]
22. [A proposal for reforming psychologists' training in France and in the European Union]. Bouchard JP Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989 [TBL] [Abstract][Full Text] [Related]
23. European regulatory perspectives for innovative therapies. Ormarsdottir S; Reginster JY; Abadie E Osteoporos Int; 2008 Jun; 19(6):725-31. PubMed ID: 18373059 [TBL] [Abstract][Full Text] [Related]
24. Counterfeiting and piracy of pharmaceuticals. Grackin A IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698 [No Abstract] [Full Text] [Related]
25. [The role of the Committee for Medicinal Products for Human Use (CHMP) in the European centralised procedure]. Enzmann H; Schneider C Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):731-9. PubMed ID: 18584106 [TBL] [Abstract][Full Text] [Related]
26. Regulatory affairs and biotechnology in Europe. I. Introduction into good regulatory practice. Tryzelaar B Biotherapy; 1988; 1(1):59-69. PubMed ID: 3079459 [TBL] [Abstract][Full Text] [Related]
27. [The European Union and drugs]. Viala G; Campion MD Ann Pharm Fr; 1995; 53(4):184-7. PubMed ID: 7574273 [TBL] [Abstract][Full Text] [Related]
28. [The regulatory framework for complementary and alternative medicines in Europe]. Knöss W; Stolte F; Reh K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103 [TBL] [Abstract][Full Text] [Related]
29. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union. Kroes BH J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408 [TBL] [Abstract][Full Text] [Related]
30. International regulatory aspects of clinical periodontal research. Cooley WE; Castellion AW Ann Periodontol; 1997 Mar; 2(1):18-30. PubMed ID: 9151540 [TBL] [Abstract][Full Text] [Related]
31. Rules governing pharmaceuticals in the European Community. Sauer F; Hankin R J Clin Pharmacol; 1987 Sep; 27(9):639-46. PubMed ID: 3680594 [TBL] [Abstract][Full Text] [Related]
32. Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval? Abraham J; Lewis G Soc Sci Med; 1999 Jun; 48(11):1655-67. PubMed ID: 10400264 [TBL] [Abstract][Full Text] [Related]
33. Legal aspects of counteracting the trafficking of falsified medicines in the european union. Pashkov V; Soloviov A; Olefir A Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815 [TBL] [Abstract][Full Text] [Related]
34. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Borg JJ; Aislaitner G; Pirozynski M; Mifsud S Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243 [TBL] [Abstract][Full Text] [Related]
35. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer. Rose K Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288 [TBL] [Abstract][Full Text] [Related]
36. Drug safety in the European community. Sauer F Drug Saf; 1990; 5 Suppl 1():141-8. PubMed ID: 2182057 [TBL] [Abstract][Full Text] [Related]
37. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan]. Pflieger M; Bertram D Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054 [TBL] [Abstract][Full Text] [Related]
38. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective. Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214 [TBL] [Abstract][Full Text] [Related]
39. Phage Therapy Regulation: From Night to Dawn. Fauconnier A Viruses; 2019 Apr; 11(4):. PubMed ID: 30999559 [TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs. Timur A; Picone G Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):251-6. PubMed ID: 19527097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]